China Product Category Factory
Active Pharmaceutical Ingredients
|
Progestogen and Estrogen
|
|
Product Name
|
Specification
|
Approved
|
CAS No.
|
|
Progesterone
|
CP/EP/USP
|
CEP/EU-GMP/FDA
|
57-83-0
|
|
Medroxyprogesterone Acetate
|
CP/EP/USP
|
DMF/GMP
|
71-58-9
|
|
Megestrol Acetate
|
CP/EP/USP
|
DMF under Filing
|
595-33-5
|
|
Mifepristone
|
CP/IP
|
DMF/GMP
|
84371-65-3
|
|
Cyproterone Acetate
|
CP/EP
|
CEP/TGA/GMP
|
427-51-0
|
|
Levonorgestrel
|
CP/EP/USP
|
DMF/GMP/CEP in process
|
797-63-7
|
|
Drospirenone
|
EP/USP
|
DMF under Filing
|
67392-87-4
|
|
Gestodene
|
CP/EP
|
DMF/GMP
|
60282-87-3
|
|
Estradiol
|
CP/EP/USP
|
DMF
|
50-28-2
|
|
Estriol
|
CP/EP/USP
|
Under R&D
|
50-27-1
|
|
Ethinyl Estradiol
|
CP/EP/USP
|
DMF/GMP
|
57-63-6
|
|
Estradiol Valerate
|
CP
|
DMF under Filing
|
979-32-8
|
|
Tibolone
|
CP/EP
|
DMF
|
5630-53-5
|
|
Dienogest
|
EP
|
DMF under Filing
|
65928-58-7
|
|
Androgen
|
|
Product Name
|
Specification
|
Approved
|
CAS No.
|
|
Finasteride
|
CP/EP/USP
|
CEP/FDA/PMDA/GMP
|
98319-26-7
|
|
Dutasteride
|
EP/USP
|
CEP/DMF
|
164656-23-9
|
|
Abiraterone Acetate
|
CP/USP
|
DMF
|
154229- 18-2
|
|
Testosterone
|
CP/EP/USP
|
DMF/CEP In-process
|
58-22-0
|
|
Testosterone Undecanoate
|
CP
|
DMF under Filing
|
5949-44-0
|
|
Testosterone Cypionate
|
USP
|
DMF under Filing
|
58-20-8
|
|
DHEA(Prasterone)
|
FP/In-house
|
DMF/WC/Kosher
|
53-43-0
|
|
Cortical Hormone
|
|
Product Name
|
Specification
|
Approved
|
CAS No.
|
|
Budesonide
|
CP/EP/USP
|
CEP/FDA/GMP
|
51333-22-3
|
|
Desonide
|
USP
|
DMF
|
638-94-8
|
|
Eplerenone
|
EP
|
CEP/FDA
|
107724-20-9
|
|
Methylprednisolone
|
CP/EP/USP
|
DMF/WC
|
83-43-2
|
|
Methylprednisolone Hemisuccinate
|
CP/EP/USP
|
DMF/WC
|
2921-57-5
|
|
Fluticasone Propionate
|
CP/EP/USP
|
DMF
|
80474-14-2
|
|
Fluticasone Furoate
|
In-house
|
Under R&D
|
397864-44-7
|
|
Others
|
|
Product Name
|
Specification
|
Approved
|
CAS No.
|
|
Oxcarbazepine
|
CP/EP/USP
|
CEP/DMF/GMP
|
28721-07-5
|
|
Eslicarbazepine Acetate
|
In-house
|
DMF under Filing
|
236395-14-5
|
|
Ganciclovir
|
CP/EP/USP
|
DMF/GMP
|
82410-32-0
|
|
Valganciclovir Hydrochloride
|
USP
|
DMF under Filing
|
175865-59-5
|
|
Oseltamivir Phosphate
|
CP/EP/USP
|
DMF
|
204255-11-8
|
|
Baloxavir marboxil
|
In-house
|
DMF in process
|
1985606-14-1
|
|
Nintedanib Esylate
|
In-house
|
DMF
|
656247-18-6
|
|
Revefenacin
|
In-house
|
DMF in process
|
864750-70-9
|
|
Mirabegron
|
In-house
|
DMF under filing
|
223673-61-8
|
|
Cariprazine Hydrochloride
|
In-house
|
DMF in process
|
1083076-69-0
|
|
Lasmiditan Succinate
|
In-house
|
DMF in process
|
439239-92-6
|
|
Luliconazole
|
In-house
|
DMF under filing
|
187164-19-8
|
|
Apalutamide
|
In-house
|
Under R&D
|
956104-40-8
|
|
Relugolix
|
In-house
|
Under R&D
|
737789-87-6
|
API Intermediates
|
Product Name
|
Specification
|
Approved
|
CAS No.
|
|
16α-Hydroxyprednisolone
|
Min99.0%
|
DMF
|
13951-70-7
|
|
16α-Hydroxyprednisolone Acetate
|
Min98.0%
|
DMF
|
86401-80-1
|
|
21-Acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione
|
Min98.0%
|
TP
|
3044-42-6
|
|
DHEA (Prasterone)
|
Min99.0%
|
DMF/WC
|
53-43-0
|
|
DHEA Acetate (Prasterone Acetate)
|
Min99.0%
|
DMF
|
853-23-6
|
|
Epiandrosterone
|
Min99.0%
|
TP
|
481-29-8
|
|
Abiraterone
|
In house
|
DMF
|
154229-19-3
|
|
Triacetyl-ganciclovir
|
Min 98.5%
|
TP
|
86357-14-4
|
|
Mono-acetyl ganciclovir
|
Min 97%
|
TP
|
194254-40-0
|
|
16-Dehydropregnenolone acetate （16-DPA）
|
Min99.0%
|
TP
|
979-02-2
|
|
Pregnenolone acetate
|
Min98.0%
|
TP/ Kosher
|
1778-02-5
|
|
Pregnenolone
|
Min99.0%
|
TP/Kosher
|
145-13-1
|
|
3-Oxo-4-androsten-17β-carboxylic acid
|
Min99.0%
|
TP
|
302-97-6
|
|
4-aza-5α-androstan-3-oxo-17β-carboxylic acid
|
Min98.0%
|
DMF
|
103335-55-3
|
|
4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic acid
|
Min98.0%
|
DMF
|
104239-97-6
|
|
N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide
|
Min98.0%
|
DMF
|
98319-24-5
|
|
6-chloro-1α-chloromethyl-3,20-dioxo-pregna-4,6-dien-17α-acetoxy
|
Min98.0%
|
DMF
|
17183-98-1
|
|
Estrone
|
USP36
|
TP
|
53-16-7
|
|
Flumethasone
|
Min98.0%
|
TP
|
2135-17-3
|
Humanwell Pharmaceutical is one of the largest API manufacture in China. With more than 20 years of experience, we develop, manufacture and trade steroid APIs, intermediates and formulations. Our market covers all over the world, we have strong presences in North America, Europe, South America and Africa, with products sold to more than 150 countries.
